The transwell assay showed that upregulation of HMGA2 could partially counteract miR-509-3-mediated inhibition on invasion of ovarian cancer cells, which indicated that miR-509-3 inhibited invasion by targeting HMGA2 (Additional file 1: Figure S1). This evidence concerns the gene HMGA2 and ovarian carcinoma.